Skip to main content
Division of Medical Oncology Oncology
  1. Division of Medical Oncology
  2. Education
  3. Fellowship Programs
  4. Combined Hematology-Oncology Track
  5. Current Fellows

Current Fellows

AY 2024-2025 UCSD HemOnc Fellows

Third Year Fellows - Class of 2025

Class of 2026

Tali Azenkot, M.D.

Hometown: San Jose, CA

Medical School: University of California, Davis

IM Residency: University of California, Davis, Sacramento, CA

What is your favorite part of UCSD fellowship?  The right balance between broad exposure and ability to tailor the fellowship experience, while living in San Diego!

Research and Career Interests:  Solid Tumor Oncology, Immune and Cellular Therapies, Biomarker Validation, Cancer informatics

Posters/Presentations/Publications:

  • Gaut D, Oliai C, Boiarsky J, Zhang S, Salhotra A, Azenkot T, Kennedy VE, Khanna V, Olmedo Gutierrez K, Shukla N, Moskoff B, Park G, Afkhami M, Patel A, Jeyakumar D, Mannis G, Logan AC, Jonas BA, Schiller G. Measurable residual disease conversion rate with consolidation chemotherapy in acute myeloid leukemia. Leuk Lymphoma. 2024 Jan;65(1):69-77. doi: 10.1080/10428194.2023.2264426. Epub 2024 Jan 10. PMID: 37801340.
  • Khanna V, Azenkot T, Liu SQ, Gilbert J, Cheung E, Lau K, Pollyea DA, Traer E, Jonas BA, Zhang TY, Mannis GN. Outcomes with molecularly targeted agents as salvage therapy following frontline venetoclax + hypomethylating agent in adults with acute myeloid leukemia: A multicenter retrospective analysis. Leuk Res. 2023 Aug;131:107331. doi: 10.1016/j.leukres.2023.107331. Epub 2023 May 29. PMID: 37263072.
  • Azenkot T, Jonas BA. Clinical Impact of Measurable Residual Disease in Acute Myeloid Leukemia. Cancers (Basel). 2022 Jul 26;14(15):3634. doi: 10.3390/cancers14153634. PMID: 35892893; PMCID: PMC9330895.
  • Azenkot T, Schwarz EB. Special Considerations for Women of Reproductive Age on Anticoagulation. J Gen Intern Med. 2022 Aug;37(11):2803-2810. doi: 10.1007/s11606-022-07528-y. Epub 2022 May 31. PMID: 35641728; PMCID: PMC9411301.
  • Azenkot T, Rivera DR, Stewart MD, Patel SP. Artificial Intelligence and Machine Learning Innovations to Improve Design and Representativeness in Oncology Clinical Trials. Am Soc Clin Oncol Educ Book. 2025 Jun;45(3):e473590. doi: 10.1200/EDBK-25-473590. Epub 2025 May 22. PMID: 40403202.

Hobbies: Yoga/ Pilates, traveling, exploring neighborhoods in San Diego

Tanim Jain, M.D.

Hometown: Queens (New York City), NY

Medical School: Donald and Barbara Zucker School of Medicine at Hofstra/Northwell

IM Residency: Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY

What is your favorite part of UCSD fellowship?  Having exposure to multiple different subspecialities within hematology/oncology, the opportunity to maintain our own patient panel at the VA, and my co-fellows

Research and Career Interests:  Malignant hematology and medical education

Posters/Presentations/Publications:

  • Snider, C. & Jain, T. “Cardiotoxicity in Malignant Hematology: A Focus on CAR T-cell Therapy.” ASH Hematopoiesis, 2024 Feb.<https://www.hematology.org/education/trainees/fellows/hematopoiesis/2024/cardiotoxicity-in-malignant-hematology-a-focus-on-car-t-cell-therapy>;  
  • Jain. T., et. al. “Outcomes of Autologous Stem Cell Transplantation for Relapsed DLBCL in Single Center Serving a Minority Population” Blood 140 (Supplement 1), 2022 Nov 15. https://doi.org/10.1182/blood-2022-170633 
  • Fedorov, K., Jain, T. et. al. “Autologous Stem Cell Transplantation in an Older Adult Population.” Haematologica, 2022 Sept; Vol 107 No 9. <https://doi.org/10.3324/haematol.2022.281020>
  • Jain, T., Swiderski, D., & LeFrancois, D. “Implementation of a framework for serious illness conversations in the ambulatory setting for internal medicine residents.” Journal of General Internal Medicine, 2022 June 17; 37 (Suppl 2): S632. Plenary presentation at SGIM 2022 Annual Meeting.
  • Jain, T. & Shaines, M. “H. pylori gastritis-associated cobalamin deficiency presenting as severe hemolytic anemia.” Journal of General Internal Medicine, 2022 June 17; 37 (Suppl 2): S458.  Poster presentation at SGIM 2022 Annual Meeting.
  • Jain, T. et. al. “Judicious Opioid Prescribing & Overdose Management: OSCEs for Third-Year Medical Students.”  Academic Medicine. 2021 Nov 1;96(11S): S189.  Poster presentation at AAMC Learn Serve Lead 2021.

Hobbies: Baking, hiking + exploring the national parks, traveling, and reading

Brian Ji, M.D., Ph.D. (PSTP)

Hometown: Madison, WI

Medical School: Columbia University

IM Residency: University of California, San Diego, La Jolla, CA

What is your favorite part of UCSD fellowship?  The breadth and depth of clinical training, the outstanding research opportunities, and the people!

Research and Career Interests:  Better understand the mechanisms of tumor growth and proliferation

Posters/Presentations/Publications: 

  • Shahin M., Ji B, Dixit P. “EMBED: Essential Microbiome Dynamics, a dimensionality reduction approach for longitudinal microbiome studies”. NPJ Systems Biology and Applications. June 2023.

  • Li Z*, Ji B*, Dixit P*, Lien E, Tchourine K, Hosios A, Tchourine K, Westermark A, Gorodetsky E, Sullivan L, Vander Heiden, M, Vitkup D. “Cancer cells depend on environmental lipids for proliferation when electron acceptors are limited”. Nature Metabolism. June 2022. *First author.

  • Ji B*, Sheth R*, Dixit P, Tchourine K, Vitkup D. "Macroecological dynamics of gut microbiota". Nature Microbiology. May 2020. *First author.

  • Ji B*, Sheth R*, Dixit P*, Huang Y, Kaufman A, Wang H, Vitkup D. "Quantifying spatiotemporal variability and noise in absolute microbiota abundances using replicate sampling". Nature Methods. August 2019. *First author.

Hobbies: Playing basketball, soccer, and keeping up with my toddler!

Eric Roth, M.D., Ph.D. (PSTP)

Hometown: Carmel, IN

Medical School: Stony Brook University

IM Residency: University of California, San Diego, La Jolla, CA

What is your favorite part of UCSD fellowship?  The close-knit, supportive, and approachable community that UCSD has fostered in part from keeping so many of their past trainees as faculty!

Research and Career Interests:  Precision medicine approaches to solid tumor oncology 

Posters/Presentations/Publications:

  • Roth E, Park SJ. Exploring Neoadjuvant Immunotherapy in Cutaneous Squamous Cell Carcinoma: Can It Eliminate the Need for Surgery and Radiation in Some Patients? ASCO Daily News. 2025 May 23
  • Ghafary I*, Kim CK*, Roth E*, Lu M*, Taub E, Lee S, Cohen I, Lu Z. The association of QTc prolongation with cardiovascular events in cancer patients taking tyrosine kinase inhibitors (TKIs). Cardiooncology. 2023 May 19;9(1):25. PMID: 37208762
  • Banach A, Jiang YP, Roth E, Kuscu C, Cao J, Lin RZ. CEMIP upregulates BiP to promote breast cancer cell survival in hypoxia. Oncotarget. 2019 Jul 2;10(42):4307-4320. PMID: 31303964
  • Roth E, Frohman MA. Proliferative and metastatic roles for Phospholipase D in mouse models of cancer. Adv Biol Regul. 2018 Jan; 67:134-140. PMID: 29154090
  • Alford VM, Roth E, Zhang Q, Cao J. A Novel Collagen Dot Assay for Monitoring Cancer Cell Migration. Methods Mol Biol. 2016; 1406:181-7. PMID: 26820955
  • Li Y, Kuscu C, Banach A, Zhang Q, Pulkoski-Gross A, Kim D, Liu J, Roth E, Li E, Shroyer KR, Denoya PI, Zhu X, Chen L, Cao J. miR-181a-5p Inhibits Cancer Cell Migration and Angiogenesis via Downregulation of Matrix Metalloproteinase-14. Cancer Res. 2015 Jul 1;75(13):2674-85. PMID: 25977338
  • Roth E, Cao J. miR-181 suppresses metastasis via MMP-14. Aging. 2015 Oct;7(10):740-1. PMID: 26527609

Hobbies: Road bicycling, trail running, snorkeling, surfing

Christina Snider, M.D.

Hometown: Augusta, GA

Medical School: Case Western Reserve University

IM Residency: Vanderbilt University Medical Center, Nashville, TN

What is your favorite part of UCSD fellowship?  My favorite part of the structure of our fellowship. While we are an academically focused program, fellows are still exposed to a variety of career paths: from academics at UCSD, to general hematology/oncology at the San Diego VA, to more industry-oriented careers.  

Additionally, I have to mention that I am so grateful for the people at UCSD, from my co-fellows, to attendings, to nursing staff, to our program admin. I know l can always reach out for help and support when needed.

Research and Career Interests:  Open-minded! I'm grateful to have the opportunity second and third year to explore different disease types and career paths.

Posters/Presentations/Publications:

  • Snider CA, Budhwani H, Logue M, Goyal P, Pugh K, Harvey M, Kassim A, Jayani R. (November, 2022). Healthcare utilization in older adults (≥70 years) undergoing cellular therapy for hematologic malignancies. Poster accepted at: Gerontological Society of America Annual Meeting; Indianapolis, IN.
  • Snider CA, Fung K, Gould F, Adema V, Kerr CM, Kongkiatkamon S, Awada H, Co M, Kuzmanovic T, Patel BJ, Gerds AT, Mukherjee S, Nazha A, Carraway HE, Radivoyevitch T, Maciejewski JP, Visconte V, Sekeres MA, Advani AS. (December, 2019). RORA is a potential prognostic biomarker and therapeutic target for patients with acute myeloid leukemia. Poster presented at: American Society of Hematology Annual Meeting; Orlando, FL.
  • Snider CA, Yang K, Mack SC, Suh JH, Chao ST, Merchant TE, & Murphy ES. Impact of radiation therapy and extent of resection for ependymoma in young children: A population-based study. Pediatric Blood & Cancer. 2017, Nov; 65(3): 1-8. PMID: 29115718.
  • Snider CA, Voss BJ, McDonald WH, & Cover TL. Growth phase-dependent composition of the Helicobacter pylori exoproteome. Journal of Proteomics. 2016, Jan; 1(130): 94-107. PMID: 26363098.
  • Snider CA, Voss BJ, McDonald WH, & Cover TL. Supporting data for analysis of the Helicobacter pylori exoproteome. Data in Brief. 2015, Dec; 5(5): 560-563. PMID: 26958609.

Hobbies: Running, cycling, yoga, exploring California, practicing Spanish and learning a little Swedish, spending time with family and friends

Alexander Tong, M.D., Ph.D.

Hometown: Dallas, TX

Medical School: Case Western Reserve University

IM Residency: University of California, San Diego, La Jolla, CA

What is your favorite part of UCSD fellowship?  Definitely the people! Attendings are thought leaders in their field yet are readily approachable, and there so many amazing mentors who graciously and freely share their time and experience with fellows. My co-fellows are wonderful humans and inspire me daily, and I love how down-to-earth and helpful everyone is to each other. Our program coordinator Eric is super organized and makes everything behind the scenes run smoothly. I really believe the people make the program and that we have the right mix at UCSD! As a parent in medicine, I also feel well supported by the fellowship and am grateful for the childcare resources and early childhood education resources available in sunny San Diego.

Research and Career Interests:  I’m interested in bone marrow transplant and am doing research on multiple myeloma immune regulation by matrix proteoglycans in the Asimakopoulos Lab: https://www.asimakopouloslab.org/research

Posters/Presentations/Publications:

 

  • Pondugula SR, Tong AA, Wu J, Cui J, Chen T. Protein phosphatase 2Cbetal regulates human pregnane X receptor-mediated CYP3A4 gene expression in HepG2 liver carcinoma cells. Drug Metab Dispos. 2010 Sep;38(9):1411-6. doi: 10.1124/dmd.110.032128. PMID: 20538721.
  • Allen F*, Tong AA*, Huang AY. Unique transcompartmental bridge: antigen-presenting cells sampling across endothelial and mucosal barriers. Front Immunol. 2016 Jun 10;7:231. doi: 10.3389/fimmu.2016.00231. Review. PMID: 27375624. (*First author)
  • Metheny L, Eid S, Lingas K, Reese J, Meyerson H, Tong A, de Lima M, Huang AY. Intra-osseous co-transplantation of CD34-selected umbilical cord blood and mesenchymal stromal cells. Hematol Med Oncol. 2016;1(1):25-29. Epub 2016 Oct 20. PMID: 27882356.
  • Chung J, Ebens CL, Radojcic V, Perkey E, Koch U, Scarpellino L, Tong A, Allen F, Wood S, Feng J, Friedman A, Granadier D, Tran IT, Chai Q, Onder L, Yan M, Reddy P, Blazar BR, Huang AY, Brennan TV, Bishop DK, Ludewig B, Siebel CW, Radtke F, Luther SA, Maillard I. Fibroblastic niches prime T cell alloimmunity through Delta-like Notch ligands. J Clin Invest. 2017 Apr 3;127(4):1574-1588. doi: 10.1172/JCI89535. PMID: 28319044.
  • Tong AA*, Hashem H*, Eid S, Allen F, Kingsley D, Huang AY. Adoptive natural killer cell therapy is effective in reducing pulmonary metastasis of Ewing Sarcoma. Oncoimmunology 2017 Mar 16;6(4):e1303586. doi: 10.1080/2162402X.2017.1303586. PMID: 28507811. (*First author)
  • Allen F, Rauhe P, Askew D, Tong AA, Nthale J, Eid S, Myers JT, Tong C, Huang AY. CCL3 enhances antitumor priming in the lymph node via IFNγ with dependency on natural killer cells. Front Immunol 2017 Oct 23. https://doi.org/10.3389/fimmu.2017.01390. PMID: 29109732.
  • Tong AA*, Forestell B*, Murphy DV, Nair A, Allen F, Myers J, Klauschen F, Shen C, Gopal AA, Huang AY*, Mandl JN*. Regulatory T cells differ from conventional CD4+ T cells in their recirculatory behavior and lymph node transit times. Immunol Cell Biol 2019 Oct;97(9):787-798. doi: 10.1111/imcb.12276. PMID: 31127976 . (*First author).
  • Papadas A, Cicala A, Kraus SG, Arauz G, Deb G, Tong A, Deming D, Asimakopoulos F. Versican in Tumor Progression, Tumor–Host Interactions, and Cancer Immunotherapy. In: Kovalszky, I., Franchi, M., Alaniz, L.D. (eds) The Extracellular Matrix and the Tumor Microenvironment. Biology of Extracellular Matrix, vol 11, p93-118. 2022 Jul 07. Springer, Cham. https://doi.org/10.1007/978-3-030-99708-3_5

Hobbies: Chasing after my two toddler kids, classical violin, sci-fi novels, anime

Second Year Fellows - Class of 2026

HemOnc Class of 2027 

Ahmed Ali, M.D.

Hometown: Fort Lauderdale, FL

Medical School: Northwestern University

IM Residency: University of Texas Health Sciences Center at Houston, Houston, TX

What is your favorite part of UCSD fellowship?  My favorite part of the UCSD fellowship is the people. The sense of camaraderie, support, and shared passion among the fellows truly makes it feel like a special place. And of course, sunny San Diego is a wonderful bonus.

Research and Career Interests:  My research focuses on elucidating how the nutrient environment shapes immune and cancer cell metabolism and on engineering novel strategies to improve the efficacy of cellular therapies. I am pursuing a career as a physician-scientist.

Posters/Presentations/Publications:

  • Keene L. Abbott*, Ahmed Ali*, Bradley I. Reinfeld*, Amy Deik, Sonu Subudhi, Madelyn D. Landis, Rachel A. Hongo, Kirsten L. Young, Tenzin Kunchok, Christopher S. Nabel, Kayla D. Crowder, Johnathan R. Kent, Maria Lucia L. Madariaga, Rakesh K. Jain, Kathryn E. Beckermann, Caroline A. Lewis, Clary B. Clish, Alexander Muir, W. Kimryn Rathmell, Jeffrey C. Rathmell, Matthew G. Vander Heiden. Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability. eLife  May 24, 2024 *First author

  • Keene L Abbott*, Ahmed Ali*, Dominick Casalena, Brian T. Do, Raphael Ferreira, Jamie H. Cheah, Christian K. Soule, Amy Deik, Tenzin Kunchok, Daniel R. Schmidt, Steffen Renner, Sophie E. Honeder, Michelle Wu, Sze Ham Chan, Tenzin Tseyang, Daniel Greaver, Peggy P. Hsu, Christopher W. Ng, Chelsea J Zhang, Ali Farsidjani, Iva Monique Gramatikov, Nicholas J Matheson, Caroline A Lewis, Clary B Clish, Matthew G. Rees, Jennifer A. Roth, Lesley Mathews Griner, Alexander Muir, Douglas S. Auld, Matthew G. Vander Heiden. Screening in physiological medium reveals differential response to compounds targeting metabolism. Cell Chem Bio. 2023 *First author

  • Gino B. Ferraro*, Ahmed Ali*, Alba Luengo*, David P. Kodack, Keene L. Abbott, Amy Deik, Divya Bezwada, Landry Blanc, Brendan Prideaux, Xin Jin, Jessica M. Possada, Jiang Chen, Christopher R. Chin, Zohreh Amoozgar, Raphael Ferreira, Ivy Chen, Kamila Naxerova, Christopher Ng, Anna M. Westermark, Mark Duquette, Sylvie Roberge, Neal I. Lindeman, Costas A. Lyssiotis, Jens Nielsen, David E. Housman, Dan G. Duda, Elena Brachtel, Todd R. Golub, Lewis C. Cantley, John M. Asara, Shawn M. Davidson, Dai Fukumura, Véronique A. Dartois, Clary B. Clish, Rakesh K. Jain** and Matthew G. Vander Heiden** Fatty acid synthesis is required for breast cancer brain metastasis. Nature Cancer. 2021 *First author

  • Keene L. Abbott, Sonu Subudhi, Raphael Ferreira, Yetiş Gültekin, Sophie C. Steinbuch, Muhammad Bin Munim, Divya L. Ramesh, Sophie E. Honeder, Ashwin S. Kumar, Michelle Wu, Jacob A. Hansen, Anna Shevzov-Zebrun, Edrees H. Rashan, Kian M. Eghbalian, Sharanya Sivanand, Anna M. Barbeau, Lisa M. Riedmayr, Mark Duquette, Ahmed Ali, Nicole Henning, Sonia E. Trojan, Millenia Waite, Tenzin Kunchok, Mayu A. Nakano, Florian Gourgue, Gino B. Ferraro, Brian T. Do, Virginia Spanoudaki, Francisco J. Sánchez-Rivera, Xin Jin, George M. Church, Rakesh K. Jain, Matthew G.Vander Heiden. Nutrient requirements of organ-specific metastasis in breast cancer. Nature Jan 7 2026

  • Afsaneh Amouzegar, Merve Hasanov, Ahmed Ali, Denai R. Milton, Julie Simon, Jene Samuels, Khalida M. Wani, Debora Alejandra Ledesma, Elizabeth M. Burton, Courtney Hudgens, Hussein A. Tawbi, Jeffrey E. Gershenwald, Alexander J. Lazar, Michael A. Davies. Association of KIT mutations with risk of central nervous system (CNS) metastasis (met) in patients (pts) with mucosal melanoma (MM). ASCO. Abstract. May 28, 2025

  • Bradley I Reinfeld*, Matthew Z Madden*, Melissa Magdalena Wolf, Anna Chytil, Jackie E Bader, Andrew Patterson, Cohen AS, Ahmed Ali, Brian T Do,Alexander Muir, Caroline A Lewis, Rachel A Hongo , Young K, Brown RE,Vera M Todd, Huffstater T, Abin Abraham, O’Neil RT, Mathew Wilson, Xin F, Mohammed N Tantawy, William Merryman, Rachel Johnson, Christopher, Williams, Emily F Mason, , Katy E Beckermann, Matthew G Vander Heiden, H Charles Manning, Jeffrey C Rathmell, Kimryn Rathmell. Cell Programmed Nutrient Partitioning in the Tumor Microenvironment. Nature. 2021

  • Mark R Sullivan*, Alicia M Darnell*, Montana F Reilly, Tenzin Kunchok, Lena, Joesch-Cohen, Daniel Rosenberg, Ahmed Ali, Matthew G Rees, Jennifer A Roth, Caroline A Lewis, Matthew G Vander Heiden. Methionine synthase is essential for cancer cell proliferation in physiological folate environments. Nature Metabolism. 2021

  • Alba Luengo, Zhaoqi Li, Dan Y. Gui, Lucas B. Sullivan, Maria Zagorulya, Brian T. Do, Raphael Ferreira, Adi Naamati, Ahmed Ali, Caroline A. Lewis, Craig J. Thomas, Stefani Spranger, Nicholas J. Matheson, Matthew G. Vander Heiden.Increased demand for NAD+ relative to ATP drives aerobic glycolysis. Molecular Cell. 2020

  • Xin Jin, Zelalem Demere, Karthik Nair, Ahmed Ali, Gino B. Ferraro, Ted Natoli, Amy Deik, Lia Petronio, Andrew A. Tang, Cong Zhu, Li Wang, Danny Rosenberg, Vamsi Mangena, Jennifer Roth, Kwanghun Chung, Rakesh K. Jain, Clary B. Clish, Matthew G. Vander Heiden, Todd R. Golub. MetMap: A map of metastatic potential of human cancer cell lines. Nature. 2020

  • Bryan Ngo, Eugenie Kim, Victoria Osorio-Vasquez, Sophia Doll, Sophia Bustraan, Roger J. Liang, Alba Luengo, Shawn M. Davidson, Ahmed Ali, Gino B. Ferraro, Grant M. Fischer, Roozbeh Eskandari, Diane S. Kang, Jing Ni, Ariana Plasger, Vinagolu K. Rajasekhar, Edward R. Kastenhuber, Sarah Bacha, Roshan K. Sriram, Benjamin D. Stein, Samuel F. Bakhoum, Matija Snuderl, Paolo Cotzia, John H. Healey, Nello Mainolfi, Vipin Suri, Adam Friedman, Mark Manfredi, David M. Sabatini, Drew R. Jones, Min Yu, Jean J. Zhao, Rakesh K. Jain, Kayvan R. Keshari, Michael A. Davies, Matthew G. Vander Heiden, Eva Hernando, Matthias Mann, Lewis C. Cantley and Michael E. Pacold. Limited Environmental Serine and Glycine Confer Brain Metastasis Sensitivity to PHGDH Inhibition. Cancer Discovery. 2020

  • Andrea Di Francisco,*, Youngshim Choi,*, Michel Bernier,*, Yinghun Zhang, Alberto Diaz-Ruiz, Miguel A. Aon, Ahmed Ali, Kevin J. Pearson, Sophie Levan, Alejandro Martin-Montalvo, Cole R. Michel, Diana M. Willmes, Christine Heinke, Placido Navas, Jose Manuel Villalba, David Siegel, Kristofer Fritz, Shyam Biswal, David Ross, and Rafael de Cabo. NQO1 Transgenesis Improves Glucose and Lipid Metabolism in Mice Fed a High-Fat Diet. Aging and Mechanisms of Disease (NPJ). 2020

  • Michel Bernier, Sarah J Mitchell, Devin Wahl, Antonio Diaz, Abhishek Singh, Wonhyo Seo, Mingy Wang, Ahmed Ali, Tamzin Kaiser, Nathan L Price, Miguel A Aon, Eun-Young Kim, Michael A Petr, Huan Cai, Alessa Warren, Clara Di Germanio, Andrea Di Francesco, Ken Fishbein, Vince Guiterrez, Dylan Harney, Yen Chin Koay, John Mach, Ignacio Navas Enamorado, Tamara Pulpitel, Yushi Wang, Jing Zhang, Li Zhang, Richard G Spencer, Kevin G Becker, Josephine M Egan, Edward G Lakatta, John O'Sullivan, Mark Larance, David G LeCouteur,Victoria C Cogger, Bin Gao, Carlos Fernandez-Hernando, Ana Maria Cuervo, Rafael de Cabo. Disulfiram Treatment Normalizes Body Weight in Obese Mice. Cell Metabolism. 2020

  • Michel Bernier, Dylan Harney, Yen Chin Koay, Antonio Diaz, Abhishek Singh, Devin Wahl, Tamara Pulpitel, Ahmed Ali, Vince Guiterrez, Sarah J Mitchell, Eun-Young Kim, John Mach, Nathan L Price, Miguel A Aon, David G LeCouteur, Victoria C Cogger, Carlos Fernandez-Hernando, John O'Sullivan, Mark Larance, Ana Maria Cuervo, Rafael de Cabo. Elucidating the mechanisms by which disulfiram protects against obesity and metabolic syndrome. Aging and Mechanisms of Disease (NPJ). 2020

  • Sarah J. Mitchell, Michel Bernier, Miguel A. Aon, Sonia Cortassa, Eun Young Kim, Evandro F. Fang, Hector H. Palacios, Ahmed Ali, Ignacio Navas Enamorado, Andrea Di Francesco, Tamzin Kaiser, Tyler B. Waltz, Ning Zhang, James L. Ellis, Peter Elliott, David W. Frederick, Vilhelm A. Bohr, Charles Brenner, David A. Sinclair, Anthony A. Sauve, Joseph A. Baur, and Rafael de Cabo. Impact of chronic nicotinamide supplementation on health and survival in mice. Cell Metabolism. 6;27(3)667-676. 2018.

  • Sarah J Mitchell, Julio Madrigal-Matute, Morten Scheibye-Knudsen, Evandro Fang, Miguel Aon, José A González-Reyes, Sonia Cortassa, Susmita Kaushik, Marta Gonzalez-Freire, Bindi Patel, Devin Wahl, Ahmed Ali, Miguel CalvoRubio, María I Burón, Vincent Guiterrez, Theresa M Ward, Hector H Palacios, Huan Cai, David W Frederick, Christopher Hine, Filomena Broeskamp, Lukas Habering, John Dawson, T Mark Beasley, Junxiang Wan, Yuji Ikeno, Gene Hubbard, Kevin G Becker, Yongqing Zhang, Vilhelm A Bohr, Dan L Longo, Placido Navas, Luigi Ferrucci, David A Sinclair, Pinchas Cohen, Josephine M Egan, James R Mitchell, Joseph A Baur, David B Allison, R Michael Anson, José M Villalba, Frank Madeo, Ana Maria Cuervo, Kevin J Pearson, Donald K Ingram, Michel Bernier, Rafael de Cabo. "Effects of Sex, Strain, and Energy Intake on Hallmarks of Aging in Mice." Cell Metabolism 2016

  • Michel Bernier, Devin Wahl, Ahmed Ali, Joanne Allard, Shakeela Faulkner, Artur Wnorowski, Mitesh Sanghvi, Ruin Moaddel, Irene Alfaras, Julie A Mattison, S. Tarantini, Zsuzsanna Tucsek, Zoltan Ugvari, Anna Csiszar, Kevin J Pearson, Rafael de Cabo. Resveratrol supplementation Ameliorates Neuronal Insults in Cortical Brain Tissue of Nonhuman Primates Fed a High-Fat/Sucrose Diet. Aging. 2016.

  • Alejandro Martin Montalvo, Yaning Sun, Alberto Diaz Ruiz, Ahmed Ali, Vincent Gutierrez, Hector H. Palacios, Jessica Curtis, Emilio Siendones, Julia Ariza, Gelareh A. Abulwerdi, Xiaoping Sun, Annie X. Wang, Kevin J Pearson, Kenneth W. Fishbein, Richard G Spencer, Miao Wang, Xianlin Han, Morten Scheibye-Knudsen, Joe A. Baur Placido Navas, Jose Manuel Villalba, Michel Bernier, Sige Zou, and Rafael de Cabo. Cytochrome b5 reductase and the control of lipid metabolism and healthspan. Aging and Mechanisms of Disease (NPJ). 2016.

  • Marta G. Novelle, Ashley David, Nathan L. Price, Ahmed Ali, Stefanie Furer Galvan, Yongqing Zhang, Kevin Becker, Michel Bernier, and Rafael de Cabo. Caloric Restriction Induces Stress Response and Inhibits B16F10 Cell Tumorigenesis Both In Vitro and In Vivo. Impact Aging. 2015.

  • Marta G Novelle, Ahmed Ali, Carlos Dieguez, Michel Bernier and Rafael de Cabo. Metformin: A Hopeful Promise in Aging Research. Cold Spring HarborPerspectives in Medicine. 2016

  • Rafael de Cabo, Lijuan Liu, Ahmed Ali, Nathan Price, Jing Zhang, Mingyi Wang, Edward Lakatta, and Pablo M Irusta. Serum from Calorie-Restricted Animals Delays Senescence and Extends the Lifespan of Normal Human Fibroblasts in vitro. Impact Aging. 2015.

Hobbies:

Hershey Dudipala, M.D.

Hometown: Akron, OH

Medical School: Northeast Ohio Medical University

IM Residency: Boston University Medical Center, Boston, MA

What is your favorite part of UCSD fellowship?  The amazing and approachable faculty here at UCSD is what really makes this place special. Some of them are known to be top clinicians and researchers in their field. UCSD also offers a diverse training environment with 3 different hospitals: VA, Jacobs Medical Center, and Hillcrest Medical Center. This allows us to treat a diverse patient population from various socioeconomic backgrounds.

Research and Career Interests:  I am interested in GU oncology, particularly clinical health outcomes and disparities in care. Also want to dip my toes into clinical trial development!

Posters/Presentations/Publications:

  • Dudipala, H., Jani, T., Gurnani, S., Morganstern-Kaplan, D., Tran, E., Edwards, K., Shalhoub, J., McKay, R. Evolving Trends in Prostate Cancer: Disparities Across Income Levels and Global Regions (1990-2019). Accepted for publication at JCO Global Oncology. August 2025. Epub pending.
  • Dudipala, H., Dabbas, M., Pandit, K., Gurnani, S.D., McKay, R.R. Defining the Role of Postoperative Radio-Hormone Therapy in Prostate Cancer. Current Oncology Reports. 2025 June 13. https://doi.org/10.1007/s11912-025-01694-y. PMID: 40506668.
  • Dudipala, H., Nazari, S., Werneck da Cunha, I., Wei, S., Elliott, A., Baca, Y., Smith, N., Geynisman, D., Brown, J., Zarrabi, K.K., Agarwal, N., Antonarakis, E., Herchenhorn, D., McKay, R. Evaluating Molecular Alteration Profiles to Distinguish Intraductal Carcinoma of the Prostate [Oral Presentation]. 2025 Feb 13. GU ASCO: Precision Oncology Alliance GU Working Group Meeting, San Francisco, CA, USA.
  • Dudipala, H., Kulke, M., Assi, H. Ectopic ACTH-Secreting Metastatic Pancreatic Neuroendocrine Tumor Initially Presenting as Gastrinoma: A Case Report. Annals of Internal Medicine Clinical Cases. 2024 June 18. https://doi.org/10.7326/aimcc.2023.0925.
  • Naik, P., Dudipala, H., Chen, Y., Rose, B., Bagrodia, A., McKay, R. The Incidence, Pathogenesis, and Management of Non-Clear Cell Renal Cell Carcinoma. Therapeutic Advances in Urology. 2024 Feb 29. https://doi.org/10.1177/17562872241232578. PMID: 38434237.
  • Kanugula, A., Adapala, R., Guarino, B., Bhavnani, N., Dudipala, H., Paruchuri, S. and Thodeti, C.K. (2024). Studying Angiogenesis Using Matrigel In Vitro and In Vivo. In: Tharakan, B. (eds) Vascular Hyperpermeability. Methods in Molecular Biology, vol 2711 (pp. 05-116). Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3429-5_9. PMID: 37776452.
  • Dudipala H., Burns L., Jani C.T., et al. Disparities in Lung Cancer Clinical Trial Discussion and Enrollment at a Safety Net Hospital. Community Health Equity Research & Policy. 2023 Dec 12. https://doi.org/10.1177/2752535X231221394. PMID: 38087807.
  • Kilic S., Zhao J., Okut H., Jani C.T., Radwan A., Dudipala H, Burns L., Tapan U. Disparities in US Lung Cancer Clinical Trial Enrollment. Journal of Racial and Ethnic Health Disparities. 2023 Aug 31. https://doi.org/10.1007/s40615-023-01776-2. PMID: 37651069.
  • Burns, L., Young, S., Jang, H., Jani, C., Radwan, A., Omari, O.A., Patel, M., Dudipala, H., De la Vega, P. B., Kulke, M., & Tapan, U. (2023, June 03). Implementation of a Housing Insecurity Screening Tool in Patients with Lung Cancer [Poster presented]. American Society of Clinical Oncology (ASCO) Annual Meeting/Chicago, IL, USA.
  • Dudipala, H., Townsend, C., Alavi, N., and Everett, P. ALK-Rearranged Lung Adenocarcinoma Initially Presenting with Cutaneous Metastases: A Case Report. Case Reports in Clinical Medicine, 12, 256-260. 2023 July. https://doi.org/10.4236/crcm.2023.127036.
  •  

Hobbies:  Polaroid photography, volleyball, and taking my cat Leela on walks!

Nicole Farha, M.D.

Hometown: Wichita, KS

Medical School: University of Kansas

IM Residency: Cleveland Clinic Foundation, Cleveland, OH

What is your favorite part of UCSD fellowship?  Learning from some of the brightest and most approachable attendings I've ever had, who treat us like colleagues and are always available and happy to help. Also, living in sunny San Diego doesn't hurt!

Research and Career Interests:  My research is in implementation science, bridging the gap between clinical medicine and the actual implementation of healthcare, with the hopes of limiting waste and maximizing efficiency of our hospital systems. In terms of career, I am still open minded!

Posters/Presentations/Publications:

  • Jayakrishnan, T. T., Sangwan, N., Barot, S. V., Farha, N., Mariam, A., Xiang, S., Aucejo, F., Conces, M., Nair, K. G., Krishnamurthi, S. S., Schmit, S. L., Liska, D., Rotroff, D. M., Khorana, A. A., & Kamath, S. D. (2024). Multi-omics machine learning to study host-microbiome interactions in early-onset colorectal cancer. NPJ precision oncology, 8(1), 146. https://doi.org/10.1038/s41698-024-00647-1
  • Jayakrishnan, T. T., Sangwan, N., Barot, S. V., Farha, N., Mariam, A., Xiang, S., Aucejo, F., Conces, M., Nair, K. G., Krishnamurthi, S. S., Schmit, S. L., Liska, D., Rotroff, D. M., Khorana, A. A., & Kamath, S. D. (2024). Multi-omics machine learning to study host-microbiome interactions in early-onset colorectal cancer. NPJ precision oncology, 8(1), 146. https://doi.org/10.1038/s41698-024-00647-1
  • Jayakrishnan, T., Mariam, A., Farha, N., Rotroff, D. M., Aucejo, F., Barot, S. V., Conces, M., Nair, K. G., Krishnamurthi, S. S., Schmit, S. L., Liska, D., Khorana, A. A., & Kamath, S. D. (2024). Plasma metabolomic differences in early-onset compared to average-onset colorectal cancer. Scientific reports, 14(1), 4294. https://doi.org/10.1038/s41598-024-54560-5
  • Farha, N., Dima, D., Ullah, F., & Kamath, S. (2023). Precision Oncology Targets in Biliary Tract Cancer. Cancers, 15(7), 2105. https://doi.org/10.3390/cancers15072105
  • Farha, N., Faisal, M. S., Allende, D. S., Sleiman, J., Shah, R., Farha, N., Funchain, P., & Philpott, J. R. (2023). Characteristics of Immune Checkpoint Inhibitor-Associated Gastritis: Report from a Major Tertiary Care Center. The oncologist, 28(8), 706–713. https://doi.org/10.1093/oncolo/oyad031
  • Farha NG, Kasi A. Docetaxel. [Updated 2024 Jun 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK537242/
  • Odeny, T. A., Farha, N., Hildebrandand, H., Allen, J., Vazquez, W., Martinez, M., Paluri, R. K., & Kasi, A. (2020). Association between Primary Perioperative CEA Ratio, Tumor Site, and Overall Survival in Patients with Colorectal Cancer. Journal of clinical medicine, 9(12), 3848. https://doi.org/10.3390/jcm9123848

Hobbies:

Chris Grant, M.D.

Hometown: Pleasanton, CA

Medical School: Medical College of Wisconsin

IM Residency: University of California, Irvine, Orange, CA

What is your favorite part of UCSD fellowship?  My favorite part of UCSD fellowship is the camaraderie we have amongst our fellows and attendings. Our attendings have a personal interest and devotion to teaching our fellows to be the incredible Heme/Onc physicians. Our fellows are extremely close knit and feel like a true family.

Research and Career Interests:  I am interested in pursuing a career in thoracic oncology where I can pursue a career as a clinical trialist helping advance the frontier of oncology and help patient’s on their cancer journey.

Posters/Presentations/Publications:  

  • Herrmann A, Grant C, et Bazhenova L Targeting MET in Advanced and Metastatic NSCLC: A Review of the Current Landscape Translational Cancer Research Pending Review

  • Azenkot T, Grant C et Bazhenova L. Targeted Agents: EGFR Case-Based Panel Discussion Case Presenters . International Lung Cancer Congress. Presentation upcoming on 2025, June 25; Huntington Beach, CA

  • Grant C, Brazel D, Cabal A, Chen WP, et Pinter-Brown L. Baseline Immunoglobulin G and Immune Function in Lymphoma: A Retrospective Analysis. Poster presentation accepted at: American Society of Hematology. 2023, December 9, San Diego, CA.

  • Grant C, Arter Z, Smith J, Seyedin S, Nourbakhsh M, Lee B, Creadore A, et Mar N Pembrolizumab as First-Line Therapy for Multifocal Myxofibrosarcoma of the Scalp Therapeutic Advances in Medical Oncology (2024) August;16 DOI:10.1177/17588359241259451

  • Grant C et Nagasaka M Neoadjuvant Therapy in EGFR Mutated Non-small Cell Lung Carcinoma: A Narrative Review Cancer Treatment Reviews (2024) March; 126:102724. DOI:10.1016/j.ctrv.2024.102724.

  • Grant C, Hagopian G, Nagasaka M Neoadjuvant Therapy in Non-Small Cell Lung Cancer: Review of the Literature. Critical Reviews in Oncology/Hematology. (2023) August; 190;104080. DOI:

  • Grant C, Hagopian G, Brazel D, Kumar P, et Moyers J. Survival impact and trends of immunotherapy use in metastatic merkel cell carcinoma in the checkpoint era: analysis of a large database. Cancer Res (2023) 83 (7_Supplement): 4404. DOI:101.1158/1538-7445.AM2023-4404

  • Grant C, Benjamin D, Cramer S, et Kalebasty AR. Remnant Never Forgotten: the Utility of Circulating Tumor DNA in Treatment Guidance of Urachal Cancer. Therapeutic Advances in Medical Oncology  (2024) February; 16 DOI:10.1177/17588359241230743

  • Hagopian G, Jiang J, Grant C, Brazel D, Kumar P, Yamamoto M, Jakowatz J, Chow W, Shen W, et Moyers JT. Survival Impact of Post-Operative Immunotherapy in Resected Stage III Cutaneous Melanomas in the Checkpoint Era. ESMO Open (2024) January; 9(2):102193. DOI: 10.1016/j.esmoop.2023.102193.

  • Grant C, Benajmin D.J., Cramer S., et Kalebasty A.R.. A Remnant Never Forgotten: The Utility of Circulating Tumor DNA in Treatment Guidance of Urachal Cancer. Poster presentation accepted at: Spotlight on Oncology, Medical Oncologists Association of Southern California. 2023, August 12, Huntington Beach, CA

  • Grant C, De Korchkovsky D., Kalebasty A.R. et Mar N.. When the Needle Just Misses the Mark: A Case Series of Extravasations of Enfortumab Vedotin-ejfv. Poster presentation accepted at: Spotlight on Oncology, Medical Oncologists Association of Southern California. 2023, August 12, Huntington Beach, CA

Hobbies:

Erin McGillivray, M.D.

Hometown: Pleasanton, CA

Medical School: Temple University

IM Residency: University of Southern California, Los Angeles, CA

What is your favorite part of UCSD fellowship?  Our continuity clinic at the VA, where we get exposure to a variety of pathology and the autonomy to manage our own panel.

Research and Career Interests:  Solid tumor oncology

Posters/Presentations/Publications:

  • McGillivray E, Ashouri K, Chatziioannou E, Gallegos JAO, Zarka J, Kechter J, Hwang AS, Zhang K, Barros M, Yeh J, Okazaki I, Crocker AB, Maeda T, Park SJ, Choi J, Andreoli M, Darwish T, Savage DJ, Kim KB, Gupta J, Shen J, Shirai K, Choi A, Pai L, Vazquez VL, Moser J, Amaral T, Hernandez Aya LF, Lutzky J, Najjar YG, Costello CM, Mangold AR, Bhatia S, Gibney GT, Farma JM, Daniels GA, Sosman J, Chandra S, Mangla A, Bollin K, Possik PA, Robles-Espinoza CD, Ito F, In GK. Combined programmed cell death protein 1 and cytotoxic T-lymphocyte associated protein 4 blockade in an international cohort of patients with acral lentiginous melanoma. Br J Dermatol. 2025 Jan 24;192(2):316-326. doi: 10.1093/bjd/ljae401. PMID: 39438074.
  • McGillivray E, Jain R, Ramamurthy C, Sheng JY, Granina E, Yu D, Lu X, Abbas AE, Dotan E, Meyer JE, Fang CY, Denlinger CS. Understanding the Challenges Faced by Esophageal and Gastroesophageal Junction Cancer Survivors. J Patient Exp. 2023 Jun 2;10:23743735231179545. doi: 10.1177/23743735231179545.
  • McGillivray E, Farma J, Savage M, Hall MJ, Luo B, Jain R, Pathologic complete response in patient with ATM mutation after neoadjuvant FOLFOXIRI plus panitumumab therapy for locally-advanced colon cancer, a case report, Clinical Colorectal Cancer (2020), doi: https:// doi.org/10.1016/j.clcc.2020.09.004.
  • McGillivray E, Andrade J, Mehta A, Ragab O, Kim G, DeClerck B, Yung E, Kelly K, Ito F, In G. Immunohistochemical Analysis of Immune Markers in Acral Lentiginous Melanoma (ALM). 2023 American Society of Clinical Oncology Annual Meeting. J Clin Oncol 41, 2023 (suppl 16; abstr e21588). DOI: 10.1200/JCO.2023.41.16_suppl.e21588
  • McGillivray E, Jain R, Ramamurthy C, Sheng J, Granina E, Yu D, Lu X, Abbas A, Dotan E, Meyer J, Fang C, Denlinger C. Associations between quality-of-life (QOL), symptom burden and demographic characteristics in long-term esophageal and gastroesophageal junction (EGEJ) cancer survivors. Annals of Oncology (2021). Volume 32 (Supplement 3) S133. DOI: https://doi.org/10.1016/j.annonc.2021.05.158
  • Dratsky D, McGillivray E, Mittal J, Handorf EA, Berardi G, Astsaturov I, Hall MJ, Yeh MC, Jain R, Fang CY. Food Insecurity and Dietary Quality in African American Patients with Gastrointestinal Cancers: An Exploratory Study. Nutrients. 2024 Sep 11;16(18):3057. doi: 10.3390/nu16183057. PMID: 39339658.
  • Shahrestani S, Sayed S, Nasrollahi T, Nasrollahi T, Huang L, McGillivray E, Chour W, Foong A, Dowlatshahi S. Association between frailty status and complications in patients undergoing surgical excision of malignant esophageal neoplasms. Ann Gastroenterol. 2023 Sep-Oct;36(5):517-523. doi: 10.20524/aog.2023.0825. Epub 2023 Jul 25. PMID: 37664228.

Hobbies:

Karen Resnick, M.D.

Hometown: Cerritos, CA

Medical School: Baylor College of Medicine

IM Residency: University of Southern California, Los Angeles, CA

What is your favorite part of UCSD fellowship?  The people!  I've found incredible support and mentorship from our UC San Diego faculty, have the privilege to care for the patients of San Diego, and have made lifelong friendships with my co-fellows.

Research and Career Interests:  I am interested in gastrointestinal oncology, targeted cancer therapeutics and immuno-oncology. 

Posters/Presentations/Publications:

  • R. Hsu, K. Resnick, P. Zang, et al. (2026) Impact of race/ethnicity and the presence of immune-related adverse events on outcomes for non-small cell lung cancer patients treated with immune checkpoint inhibitors. Therapeutic Advances in Medical Oncology. March (18). https://doi.org/10.1177/17588359261423890
  • K. Resnick,  J. Chang, E. Connors,  et al. (2026) Molecular Predictors of Response in first line tremelimumab plus durvalumab in patients with advanced hepatocellular carcinoma.  HCC-LIVE Poster presentation.
  • K. Resnick, A. Shah, J. Mason, P. Kuhn, J. Nieva, S. Shisheido. (2024) Circulation of rare events in the liquid biopsy for early detection of lung mass lesions. Thoracic Cancer 2024. Oct;15(29):2100-2109. doi: 10.1111/1759-7714.15429. PMID: 39233479.
  • A. Ginosyan, K. Ashouri, B. Ho, J. Hwang, K. Resnick, et al. (2024) Blinatumomab Therapy for Low Level Minimal Residual Disease Detected By Next-Generation Sequencing in Adult B-Cell Acute Lymphoblastic Leukemia. Transplantation and Cellular Therapy. 30:2_S109-S110. doi: https://doi.org/10.1016/j.jtct.2023.12.173
  • K. Ashouri, B. Hom, M. Chu, J. Hwang, K. Resnick, et al. (2023) B-Cell Acute Lymphoblastic Leukemia: Donor Matters in Allogeneic Stem Cell Transplant Outcomes of Hispanic Patients. Blood 2023 142 (S1): 2241. doi: https://doi.org/10.1182/blood-2023-190541.
  • K. Ashouri, B. Hom, Y. Rahimi, K. Resnick, V. Nittur, et al. (2023) Philadelphia-like B-Cell Acute Lymphoblastic Leukemia in a Largely Hispanic Population: Disease Features and Outcomes in the Era of Immunotherapy a Single Institutional Study. Blood 2023 142(S1): 4208. doi: https://doi.org/10.1182/blood-2023-190716.
  • D. Chen, K. Resnick, L. Chow, G. Yaghmour. (2023) Allogenic Hematopoietic Stem Cell Transplant Outcomes in Elderly Patients: A Single Institution Study.  Transplantation and Cellular Therapy. 29:25_suppl S438. 
  • P. Zang, K. Resnick, T. Larsen, et al. (2022) Impact of steroid use among patients with renal cell carcinoma (RCC) who develop immune-related adverse events (irAE). Journal of Clinical Oncology 2022 40:16_suppl, 4530-4530.
  • U. Giri, X. Yu, K. Resnick, et al. (2021) Venous Thromboembolism in patients on check point inhibitors. Journal of Clinical Oncology 2021 39:15_suppl, e14582-e14582

Hobbies: Exploring all the beaches San Diego has to offer

Parth Sheth, M.D. (Hematology Track)

Hometown: Santa Rosa, CA

Medical School: University of Southern California

IM Residency: Loma Linda University, Loma Linda, CA

What is your favorite part of UCSD fellowship?  I truly appreciate our exposure to complex hematologic cases while working alongside exceptional faculty who create a respectful environment of learning. Also, you can not beat living in the best city int he country!

Research and Career Interests:  Classical hematology with a focus in hemostasis & thrombosis

Posters/Presentations/Publications:

  • Whang, S., Shah, V., Pu, L., Sheth, P., Lucas, G., Lee, J., Lee, M., Lacy, C., Duerksen-Hughes, P., Filippov, V., Lee, D., Veltman, J., Maken, K., Reeves, M., Stevens, W., Herrmann, P., Cao, H., Lau, E. Convalescent Plasma for Covid-19: A Single Center Prospective Experience with Serial Antibody Measurements and Review of the Literature. Pathogens. 2022; 11(9):958
  • Ran-Castillo D.*, Sheth P.*, Nishino K., Stevens T., Nguyen A., Mirshahidi H. Successful treatment of autoimmune hemolytic anemia concomitant with proliferation of Epstein-Barr virus in a post-heart transplant patient. Hematology Reports. 2022; 14(3):261-264
  • Fahradyan A., Howell A.C., Wolfswinkel E.M., Tsuha M., Sheth P., Wong A.K. Updates on the management of non-melanoma skin cancer (NMSC). Healthcare. 2017; 5:82.
  • Delaney J.R., Patel C.B., Willis K., Haghighiabyaneh M., Axelrod J., Tancioni I., Lu D., Bapat J., Young S., Cadassou O., Bartakova A., Sheth P., Haft C.,  Hui S., Saenz C., Schlaepfer DD., Harismendy O., Stupack DG. Haploinsufficiency networks identify targetable patterns of allelic deficiency in low mutation ovarian cancer. Nature Communications. 2016; 8:14423.
  • Sheth, P., Glenzer, M., Nwi-Mozu, I., Aguero, P., Steiner, B., Bailey, C., Quon, D., Kruse-Jarres, R., von Drygalski, A. (2024, June 22). Use of the Joint Activity Damage Exam (JADE) ultrasound protocol for hemophilic joint assessment enables determination of annual rate changes of intraarticular tissue measurements. International Society of Haemostasis and Thrombosis Congress/Bangkok, Thailand. (Oral Presentation)
  • Sheth, P., Glenzer, M., Nwi-Mozu, I., Aguero, P., Steiner, B., Bailey, C., Quon, D., Kruse-Jarres, R., von Drygalski, A. (2024, 9 December). Assessment of Annual Rate Changes of Intraarticular Tissue Measurements in Hemophilic Joints Experiencing Acute Bleeding Using the Joint Activity Damage Exam (JADE) Ultrasound Protocol. ASH Annual Meeting & Exposition/San Diego, CA. (Poster Presentation)

Hobbies:

First Year Fellows - Class of 2027

Class of 2028 

John Bliamptis, M.D.

Hometown: Wilmette, IL

Medical School: Johns Hopkins Univeristy School of Medicine

IM Residency: University of California, San Diego

Ashwin Ganti, M.D.

Hometown: Freemont, CA

Medical School: Rush University

IM Residency: Mayo Clinic, Rochester, MN

Hannah King, D.O. (Hematology Track)

Hometown: Goodyear, AZ

Medical School: Arizona College of Osteopathic Medicine

IM Residency: Oregon Health and Sciences University

Adam Kolawa, M.D.

Hometown: Monrovia, CA

Medical School: University of Southern California, Los Angeles, CA

IM Residency: University of Southern California, Los Angeles, CA

Jacob Leary, M.D.

Hometown: Greencastle, PA

Medical School: University of Colorado

IM Residency: University of Washington

Alex Lee, M.D.

Hometown: Saratoga, CA

Medical School: University of California, Davis

IM Residency: Stanford University

Zoya Qureshy, M.D.

Hometown: San Jose, CA

Medical School: University of California, San Francisco

IM Residency: University of California, San Diego